ICMR & Panacea Biotec complete enrollment for India's first indigenous dengue vaccine phase 3 study
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
Blood tests measuring biomarkers such as p-tau217 are emerging as accurate, accessible alternatives
REDEMPLO is the first and only Health Canada-approved siRNA therapy for FCS
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
Currently approved for patients eight and older, Tzield could now be used to delay the onset of stage 3 type 1 diabetes (T1D) in children diagnosed with stage 2 T1D
Heart failure affects an estimated 64.3 million people worldwide
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
Before this appointment, he served as the Secretary in the Department of Land Resources, Ministry of Rural Development
Subscribe To Our Newsletter & Stay Updated